176 related articles for article (PubMed ID: 11109977)
1. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
[TBL] [Abstract][Full Text] [Related]
2. Association between female sex hormones and biochemical markers of bone turnover in peri- and postmenopausal women.
Peichl P; Griesmacher A; Pointinger P; Marteau R; Hartl W; Gruber W; Bröll H
Calcif Tissue Int; 1998 May; 62(5):388-94. PubMed ID: 9541515
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers in menopausal women.
Griesmacher A; Peichl P; Pointinger P; Mateau R; Bröll H; Hartl W; Gruber W
Scand J Clin Lab Invest Suppl; 1997; 227():64-72. PubMed ID: 9127469
[TBL] [Abstract][Full Text] [Related]
4. Bone turnover markers and estradiol level in postmenopausal women.
Sypniewska G; Chodakowska-Akolinska G
Clin Chem Lab Med; 2000 Nov; 38(11):1115-9. PubMed ID: 11156339
[TBL] [Abstract][Full Text] [Related]
5. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers.
Peichl P; Griesmacherb A; Marteau R; Hejc S; Kumpan W; Müller MM; Bröll H
Clin Biochem; 2001 Mar; 34(2):131-9. PubMed ID: 11311223
[TBL] [Abstract][Full Text] [Related]
6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
[TBL] [Abstract][Full Text] [Related]
8. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy.
Hall GM; Spector TD; Delmas PD
Arthritis Rheum; 1995 Jul; 38(7):902-6. PubMed ID: 7612039
[TBL] [Abstract][Full Text] [Related]
9. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
[TBL] [Abstract][Full Text] [Related]
10. Effect of norethindrone acetate on hormone levels and markers of bone turnover in estrogen-treated postmenopausal women.
Onobrakpeya OA; Fall PM; Willard A; Chakravarthi P; Hansen A; Raisz LG
Endocr Res; 2001 Nov; 27(4):473-80. PubMed ID: 11794470
[TBL] [Abstract][Full Text] [Related]
11. Bone turnover markers and bone density across the menopausal transition.
Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of urinary CrossLaps as a sensitive marker of bone metabolism.
Nakayama H; Yano T; Sagara Y; Ando K; Kasai Y; Taketani Y
Endocr J; 1997 Aug; 44(4):479-84. PubMed ID: 9447279
[TBL] [Abstract][Full Text] [Related]
13. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the contribution of dydrogesterone to bone turnover changes in postmenopausal women commencing hormone replacement therapy.
Tobias JH; Clarke S; Mitchell K; Robins S; Amer H; Fraser WD
J Clin Endocrinol Metab; 2001 Mar; 86(3):1194-8. PubMed ID: 11238508
[TBL] [Abstract][Full Text] [Related]
15. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
[TBL] [Abstract][Full Text] [Related]
16. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
Azizi G; Hansen A; Prestwood KM
Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
[TBL] [Abstract][Full Text] [Related]
17. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
[TBL] [Abstract][Full Text] [Related]
18. Markers of bone resorption--measurement in serum, plasma or urine?
Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
[TBL] [Abstract][Full Text] [Related]
19. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.
Sowers MR; Greendale GA; Bondarenko I; Finkelstein JS; Cauley JA; Neer RM; Ettinger B
Osteoporos Int; 2003 May; 14(3):191-7. PubMed ID: 12730778
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers of bone turnover during hormone replacement therapy.
Masahashi T; Negoro Y; Kuroki T; Asai M; Noguchi M; Nakanishi M
Int J Gynaecol Obstet; 1999 Feb; 64(2):163-6. PubMed ID: 10189026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]